Tesla Supplier CATL Sets Modest Underwriting Fees For World's Biggest IPO Of 2025
AST SpaceMobile Sets $75 Million Target For 2025 As CFO Andrew Johnson Says 'Revenue Is Ramping On Plan' Amid Surging Demand For Direct-To-Device Satellite Connectivity
"Don't sell if prices don't drop!" Trump enforces a mandatory minimum drug price for developed countries, but a lawsuit battle may be "reenacted".
① An executive order signed on the 12th of October, USA time, requires that the payment price of pharmaceuticals in the USA be forcibly anchored to the lowest level of other developed countries within 30 days; ② There is strong opposition within the USA, and industry experts estimate that a legal battle is about to "replay"; ③ As the market-oriented USA begins to wield the big stick of administrative pricing, the underlying rules of the game for Innovative Drugs have quietly been rewritten.
U.S. stock market close: The Nasdaq surged over 4%, Chinese concept stocks performed even stronger, and the Golden Dragon Index outperformed the Large Cap.
① High-level economic and trade talks between China and the U.S. exceeded expectations, boosting U.S. stocks; ② Both the S&P and Nasdaq hit new closing highs since March 3; ③ NVIDIA rose over 5%, with its Market Cap returning to above 3 trillion; ④ Trump: Will investigate pharmaceutical companies if necessary.
AbbVie Unusual Options Activity
Shell Hit With Delay in U.S. Gulf Deepwater Oil Development
The "Most-Favored-Nation Pricing" policy for Trump Medicine has been issued: benchmarked against developed countries, complete the Quote within 30 days.
① This policy aims to align prescription drug pricing in the USA with that of "Other developed countries". Trump has requested that the Quote be completed within 30 days; ② The scope of affected Pharmaceuticals is still unclear, and the White House has stated that the government will pay special attention to drugs that have the "largest price differences and highest spending"; ③ Trump had implemented a similar policy before the end of his last term, but it was blocked by the courts and ultimately fell through.
SA Analyst Upgrades: META, GS, DUK, MSTR, FSLY, TRIN
Congressional Trading Report: Rep. Jared Moskowitz Bought Over $27K In AbbVie Stock
Roche Plans $700M North Carolina Facility
Innovation, Pharma Profits Won't Suffer Under Trump Prescription Drug EO - White House
Tobacco Stocks Fall Back as Risk-on Trading Sweeps Back Over the Market
Trump's Drug Price Cuts: Will They Work?
Mark Cuban Reveals Lost Broadcast.com Patents That Could've Shaped Tech's Future — Still Willing To Buy It Back, 'If Anyone There Cares'
Is it meaningful for Shell to acquire BP?
UBS Group predicts that after the merger, the company will become the largest Oil and gas producers in the Global, with daily Crude Oil Product and Henry Hub Natural Gas production reaching nearly 5 million barrels of oil equivalent, an 85% increase compared to Shell's current daily production of about 2.7 million barrels. However, Bank of America believes that, given the historical dilution of cash flow per share from Shell's acquisition of BG, under the current backdrop of declining oil prices, stock buybacks by Shell may be a 'wiser choice.'
China's Zijin Mining Taps Banks for Planned Hong Kong IPO of Gold Unit - Report
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Weekly Earnings Scoreboard: Eight Out of 10 Utility Companies Deliver EPS Wins
U.S. Pharma Imports Soar in March as Drugmakers Look to Get Ahead of Potential Tariffs
10 Health Care Stocks With Whale Alerts In Today's Session